North-West University Faculty of Humanities, North-West University, Mafikeng, South Africa.
BMC Public Health. 2021 Nov 5;21(1):2013. doi: 10.1186/s12889-021-12020-z.
Cervical cancer (CC) is the cancer with the most incidents and the leading cause of cancer mortality among women in South Africa. CC screening is one of the most cost-effective control approaches for the disease burden. This study assessed the determinants and individual-level indicators of cervical cancer screening uptake among women of reproductive age in South Africa.
We analyzed data from the 2016 South Africa Demographic Health Survey. Our analysis focused on 5903 women (15-49 years). We conducted Chi-square test for bivariate analysis, and multivariate binary logistics regression was used to analyze independent association between individual-level factors and women who have had Pap smear testing. Statistical significance was set at p < 0.05.
The mean age at cervical cancer screening uptake among women in South Africa was 40.8 years (SD 18.6, range 15-95 years). A majority of the women (39.3%) were aged 45 years and above and 54.6% of them resides in urban settlements. About 35.4% of women (n = 2098) have had a Pap smear test, with 66.5% of them who had a Pap smear test resides in Western Cape province. The proportion of women who had a Pap smear test was significantly higher among those with higher educational attainment (68.7%, p = 0.000), in the rich wealth index (50.1%, p = 0.000), and those with health insurance cover (60.3%, p = 0.000). Pap smear testing was found to be more prevalent among women aged 45 years, were in the white population group, had higher education, were divorced, and had health insurance cover. The predominance of Pap smear test was 14% higher among women who are working in the professional/formal sector (AOR; 1.38, 95% CI; 1.14-1.69). The uptake of Pap smear test was also higher among women aged 35-44 years.
The prevalence of cervical cancer uptake is substantially low among women aged 15-24 years in South Africa and shows a degree of between-provinces differences. Therefore, heath educational interventions aimed at increasing the uptake of cervical cancer screening services in South Africa are critically needed.
在南非,宫颈癌(CC)是发病率最高的癌症,也是女性癌症死亡的主要原因。宫颈癌筛查是控制疾病负担最具成本效益的方法之一。本研究评估了南非育龄妇女接受宫颈癌筛查的决定因素和个体水平指标。
我们分析了 2016 年南非人口与健康调查的数据。我们的分析集中在 5903 名妇女(15-49 岁)。我们进行了卡方检验进行双变量分析,并用多元二项逻辑回归分析了个体因素与接受巴氏涂片检查的妇女之间的独立关联。统计显著性设为 p < 0.05。
南非妇女接受宫颈癌筛查的平均年龄为 40.8 岁(标准差 18.6 岁,范围 15-95 岁)。大多数妇女(39.3%)年龄在 45 岁及以上,其中 54.6%居住在城市住区。约有 35.4%的妇女(n=2098)接受了巴氏涂片检查,其中 66.5%居住在西开普省。在受教育程度较高(68.7%,p=0.000)、财富指数较高(50.1%,p=0.000)和有医疗保险的妇女中,接受巴氏涂片检查的比例显著较高。巴氏涂片检查在 45 岁及以上、白人、受过高等教育、离婚和有医疗保险的妇女中更为常见。在从事专业/正规部门工作的妇女中,巴氏涂片检查的比例高出 14%(优势比;1.38,95%置信区间;1.14-1.69)。35-44 岁的妇女接受巴氏涂片检查的比例也较高。
南非 15-24 岁妇女接受宫颈癌筛查的比例较低,且存在一定程度的省份间差异。因此,迫切需要开展卫生教育干预,以提高南非宫颈癌筛查服务的利用率。